



 DOI: 10.1159/000356525 
 Immunology of Psychiatric Disorders
 Antonio Lucio Teixeira  a     Norbert Müller  b 
 a 
  Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Instituto de Estudos Avançados 
Transdisciplinares, Universidade Federal de Minas Gerais (UFMG),  Belo Horizonte , Brazil;  b   Department of Psychiatry 
and Psychotherapy, Ludwig-Maximilian  University of Munich,  Munich , Germany
 
 
changes that take place after an inflammatory condition. 
Subsequently, great interest was directed towards inves-
tigating a pathogenic role of infectious (e.g. toxoplasmo-
sis) and noninfectious (e.g. autoimmunity) mediated in-
flammation in psychiatric disorders. Now, immune sys-
tem-related molecules are being regarded either as 
putative biomarkers or as pharmacological targets.
 This supplement of  Neuroimmunomodulation presents 
the ‘state of the art’ of the immunology of psychiatric dis-
orders. The manuscripts discuss the available data on the 
characterization of the immune/inflammatory dysfunc-
tion in the most relevant psychiatric disorders, associa-
tions with cognitive and behavioral symptoms, and poten-
tial biomarkers and targets for therapeutic development.
 
 Recent reports on the Global Burden of Diseases, Inju-
ries and Risk Factors Study 2010  [1, 2] demonstrated the 
significant burden associated with psychiatric disorders, 
with growing challenges for health systems. For instance, 
psychiatric disorders, including substance use disorders, 
were the leading cause of years lived with disability (YLD) 
worldwide, accounting for 22.9% of all YLD  [2] . To change 
this picture the prevention and treatment of psychiatric 
disorders must be regarded as a social priority.
 Complicating the scenario, the advancement of knowl-
edge on the neurobiology of psychiatric disorders has not 
been translated into new or more effective pharmacolog-
ical interventions. Facing growing costs and the exhaus-
tion of amine-based strategies, part of the pharmaceutical 
industry has even withdrawn research and development 
in psychiatry. Furthermore, the promises of understand-
ing the genetic basis of individual psychiatric disorders 
with genome-wide association studies did not materialize 
as shared genetic etiology for major psychiatric disorders 
was reported  [3] .
 The immune system is traditionally regarded as a host 
defense system. In recent years, however, its homeostatic 
role has been emphasized  [4] . The immune system works 
in association with other systems, particularly nervous 
and endocrine systems, to maintain body homeostasis. 
Corroborating this view, immune changes have been de-
scribed in association with several noninfectious condi-
tions, like physical exercise, weight gain/obesity, aging 
and psychiatric disorders.
 The initial approach to the role of the immune system 
in behavior dates back to the study of ‘sickness behavior’, 
i.e. a set of depressive-like cognitive and behavioral 
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